MedWorld Advisors
MedWorld Advisors is a Florida-based boutique M&A advisory firm providing sell-side and buy-side transaction services to small and mid-market medical device, MedTech, BioTech, dental, life sciences, and digital health companies globally.
- Company typePrivate
- Founded2015
- HeadquartersAndover, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MedWorld Advisors does
MedWorld Advisors is a boutique mergers and acquisitions advisory firm founded approximately in 2013-2015, headquartered in Loxahatchee, Florida, that provides sell-side and buy-side M&A advisory services to small and mid-market healthcare and life-sciences companies. Its target sectors span medical devices, MedTech, BioTech, dental, life sciences, digital health, and medical/dental practices, with named engagements including the JLL Partners acquisition of Vascular Technology, Inc. and Parks Medical Electronics (2025), the CentralReach acquisition of Behavior Sciences Technology (2024), and the Afinum 9 formation of the MedTech Laser Group from A.R.C. Laser GmbH and G.N.S. neoLaser Ltd. (2024). The firm's value proposition rests on Fortune 500 operating experience from both sides of the M&A table — primarily through co-founder Dave Sheppard (Medtronic/Covidien, BD/Bard) and CEO Florence Joffroy-Black — and on a global cross-border deal network spanning the US, Europe, the Middle East, and Asia.
The firm monetizes through professional services fees on a quote-based, multi-year engagement basis, with no publicly disclosed pricing. There is no software product, platform, or API offering (api_details confirms none); the deliverable is bespoke advisory work, not a recurring technology stack. Its registered brand asset "Value = Strategic Fit + Timing®" encapsulates its advisory framework, and go-to-market is anchored on thought leadership published in Medical Product Outsourcing, Today's Medical Developments, and Orthopedic Design & Technology, plus active speaking and panel hosting at ODT Forum, MD&M West, AAOS, and The MedTech Conference. The firm is privately held and founder-led, with no reported outside funding rounds, no parent company, and a stated headcount band of 11-50 employees organized around a four-person leadership team.
Operationally, the firm operates on a deal-by-deal basis without recurring subscription revenue, making revenue inherently lumpy and tied to transaction closings. Expansion has been steady rather than venture-scale: incremental cross-border deals, broader sector coverage (notably into digital health via the BST/CentralReach mandate), and growing 2026 conference and content footprint. The competitive set is not bulge-bracket investment banks but mid-market healthcare-focused advisors where relationships, sector specialization, and operator credibility are the primary defensible assets.
MedWorld Advisors firmographics
Firmographics- Name
- MedWorld Advisors
- Legal name
- MedWorld Advisors
- Website
- https://medworldadvisors.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MedWorld Advisors is a Florida-based boutique M&A advisory firm providing sell-side and buy-side transaction services to small and mid-market medical device, MedTech, BioTech, dental, life sciences, and digital health companies globally.
- Ownership category
- akta.pro rank
MedWorld Advisors industry classification
Industry- Product category
- M&A Advisory Services
- NAICS
- Management Consulting Services (54161), Administrative Management and General Management Consulting Services (541611)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- M&A Advisory (Buy-side/Sell-side) (BPAHADAC)
- akta.pro secondary industries
- M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Sell-Side M&A Advisory (FSAEAGAA), Buy-Side M&A Advisory (FSAEAGAB)
Keywords
Where MedWorld Advisors is headquartered
LocationHeadquarters
- HQ city
- Andover
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MedWorld Advisors business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- M&A Sell-Side Advisory: Advisory services helping small to medium-sized healthcare companies sell their businesses, maximize value, and navigate M&A transactions including MBO, LBO, or recapitalization options.
- M&A Buy-Side Advisory: Extended business development team services helping clients find target investments, qualify acquisition opportunities, and increase company value through strategic acquisitions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom advisory engagement pricing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
MedWorld Advisors product offering
Product offeringCore offering
MedWorld Advisors is a boutique M&A advisory firm that provides sell-side and buy-side advisory services to small and medium-sized Medical Device, MedTech, BioTech, Dental, Life Sciences, Digital Health, and other Healthcare companies. The firm helps business owners sell their companies and maximize enterprise value (covering MBO, LBO, or recapitalization options), and acts as an extended business development team to find and qualify acquisition targets for strategic and financial buyers on a global basis. Its advisory approach is anchored by its proprietary 'Value = Strategic Fit + Timing®' framework and leverages Fortune 500 experience from both sides of M&A transactions.
Product overview
MedWorld Advisors is a boutique M&A advisory firm offering sell-side and buy-side advisory services for small to medium-sized healthcare, medtech, biotech, dental, life sciences, digital health, and medical practice companies. Their core offerings include M&A Sell Side advisory (helping business owners sell and maximize enterprise value) and M&A Buy Side advisory (acting as extended business development teams to find acquisition targets). The firm's proprietary framework 'Value = Strategic Fit + Timing' underpins their advisory approach. They do not offer a software product platform but rather provide expert advisory services leveraging Fortune 500 experience to position clients with global buyers.
Differentiator
Problem solved
Functional benefit
Products and services
- M&A Sell Side Advisory
Quantifiable outcome
- 23% more value for sellers who hire outside advisors vs managing own M&A sales process (according to independent studies cited by the firm)
- +1 more outcomes
Companies that use MedWorld Advisors
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
MedWorld Advisors technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MedWorld Advisors partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Vascular Technology, Inc.coreMedWorld Advisors served as advisor to Vascular Technology, Inc. in their sale to middle market PE firm JLL Partners. Vascular Technology is a medical device company specializing in innovative surgical devices and single-use consumables for the operating room.
- CentralReachminorMedWorld Advisors supported the acquisition of Behavior Sciences Technology (BST) in its strategic sale to CentralReach, the leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education.
- Medical Product Outsourcing MagazinecoreOngoing content partnership with MPO Magazine for thought leadership articles and webinar hosting including 'The DNA of Successful M&A Process' webinar.
- Today's Medical Developments MagazinecoreRegular column contributions and content partnership with Today's Medical Developments Magazine covering medtech industry trends and M&A insights.
- Orthopedic Design & Technology Magazine (ODT)coreRegular column contributions and conference participation with ODT Magazine including AAOS coverage and ODT Forum speaking engagements.
- Florida Medical Tech (Florida MedTech)minorIndustry association membership and partnership supporting Florida's medical technology ecosystem.
- MassMedicminorAssociation membership in Massachusetts medical technology association representing medtech companies in a major U.S. medtech hub.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
MedWorld Advisors competitors and assessment
Company assessmentDirect peers
- Ziegler (Healthcare Investment Banking): Specialty investment bank with a healthcare M&A practice serving middle-market healthcare and senior living clients. Comparable in serving founder- and sponsor-owned healthcare businesses with M&A and capital advisory.
- MTS Health Partners: Healthcare-focused boutique investment bank providing M&A advisory and capital raising services to medical device, life sciences, and healthcare services companies. Highly comparable to MedWorld given its sector specialization and mid-market focus.
- Provident Healthcare Partners: Boutique investment bank exclusively focused on healthcare M&A advisory for middle-market companies. Direct competitor to MedWorld Advisors in the healthcare sell-side and buy-side advisory space, serving similar-sized medical device, services, and life sciences clients.
- Carl Marks Advisors: Middle-market M&A advisory firm with a healthcare practice. Overlaps with MedWorld in providing sell-side and buy-side advisory to lower-mid-market healthcare and consumer products companies.
- BGL (Brown Gibbons Lang & Company): Independent investment bank with a dedicated Healthcare & Life Sciences M&A group serving middle-market clients. Competes with MedWorld in sell-side advisory and recapitalization mandates for medical device and healthcare services companies.
- Edgemont Capital Partners: Healthcare-dedicated M&A advisory firm focused on middle-market transactions in medical devices, life sciences, and healthcare services. Directly comparable boutique model and sector focus to MedWorld Advisors.
- TripleTree (TT Capital Partners): Healthcare-focused investment bank and merchant bank advising on M&A, capital raising, and strategic advisory for healthcare technology and services companies. Comparable boutique healthcare M&A model to MedWorld.
Broad incumbents
- Leerink Partners: Healthcare-focused full-service investment bank covering medical devices, life sciences, and healthcare services. Operates at a larger scale and broader mandate than MedWorld but competes for overlapping healthcare M&A and advisory engagements.
- KPMG (Healthcare M&A Advisory): Big Four firm with a global healthcare M&A and deal advisory practice. Competes with MedWorld for mid-market healthcare sell-side and buy-side mandates where clients need a larger platform and cross-border execution.
- EY-Parthenon (Healthcare M&A): Global strategy and transactions advisory practice with a dedicated healthcare M&A team. Overlaps with MedWorld in mid-market healthcare transactions and represents the larger, broader incumbent competition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
MedWorld Advisors social profiles
Digital presenceMedWorld Advisors financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedWorld Advisors leadership team
Management profileNumber of profiles
Profiles4 records
MedWorld Advisors funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedWorld Advisors M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedWorld Advisors
What does MedWorld Advisors do?
MedWorld Advisors is a boutique M&A advisory firm that provides sell-side and buy-side advisory services to small and medium-sized Medical Device, MedTech, BioTech, Dental, Life Sciences, Digital Health, and other Healthcare companies. The firm helps business owners sell their companies and maximize enterprise value (covering MBO, LBO, or recapitalization options), and acts as an extended business development team to find and qualify acquisition targets for strategic and financial buyers on a global basis. Its advisory approach is anchored by its proprietary 'Value = Strategic Fit + Timing®' framework and leverages Fortune 500 experience from both sides of M&A transactions.
Is MedWorld Advisors a public or private company?
MedWorld Advisors is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MedWorld Advisors founded?
MedWorld Advisors was founded in 2015. It employs 11 to 50 people.
Where is MedWorld Advisors based?
MedWorld Advisors is headquartered in Andover, United States, in the North America region.
How does MedWorld Advisors make money?
Two revenue lines are on record. M&A Sell-Side Advisory is the primary driver. The others are M&A Buy-Side Advisory.
Who are MedWorld Advisors's main competitors?
Direct peers on record are Ziegler (Healthcare Investment Banking), MTS Health Partners, Provident Healthcare Partners, Carl Marks Advisors, BGL (Brown Gibbons Lang & Company), Edgemont Capital Partners and TripleTree (TT Capital Partners). Broad incumbents are Leerink Partners, KPMG (Healthcare M&A Advisory) and EY-Parthenon (Healthcare M&A).
Does MedWorld Advisors have an API?
No public API is recorded for MedWorld Advisors.
What industry is MedWorld Advisors in?
MedWorld Advisors's product category is M&A Advisory Services. Its primary akta.pro industry code is BPAHADAC, M&A Advisory (Buy-side/Sell-side), with a secondary code of BPAHAOAA, M&A Advisory (Buy-Side & Sell-Side). Its NAICS code is 54161 and its SIC code is 8742.